EXFORGE HCT 10/160/12.5 TAB 1'S

Exforge HCT 10/160/12.5 is a triple-combination antihypertensive tablet by Novartis containing amlodipine, valsartan, and hydrochlorothiazide. This formulation is designed for patients requiring multi-drug therapy to manage hypertension effectively. Amlodipine works as a calcium channel blocker, valsartan as an ARB, and hydrochlorothiazide as a thiazide diuretic, providing complementary mechanisms for blood pressure control. Suitable for patients whose condition is inadequately controlled with dual therapy. Each tablet delivers precise dosing for consistent therapeutic outcomes in cardiovascular management.